##4080434
We	we	ppis2
conducted	conduct	vvd
a	a	at1
randomized	randomized	jj@
,	,	y
controlled	control	vvd_vvn
,	,	y
double-blind	double-blind	jj_nn1@
,	,	y
prospective	prospective	jj
study	study	nn1
to	to	to
evaluate	evaluate	vvi
the	the	at
effect	effect	nn1
of	of	io
intraoperative	intraoperative	jj
bupivacaine	bupivacaine	nn1
injection	injection	nn1
on	on	ii
postoperative	postoperative	jj
pain	pain	nn1
control	control	nn1_vv0
following	following	ii@_vvg
Bovie		np1
cautery-assisted	cautery-assisted	jj_nn1
tonsillectomy	tonsillectomy	nn1
in	in	ii
26	26	mc
adults	adult	nn2
.	.	y
Sixteen	sixteen	mc
patients	patient	nn2
were	be	vbdr
injected	inject	vvn
with	with	iw
10	10	mc
ml	ml	nnu
of	of	io
0.5%	0.5%	fo
bupivacaine	bupivacaine	vv0_nn1
with	with	iw
1:200,000	1:200,000	mc
epinephrine	epinephrine	jj_nn1
,	,	y
and	and	cc
10	10	mc
were	be	vbdr
injected	inject	vvn
with	with	iw
10	10	mc
ml	ml	nnu
of	of	io
normal	normal	jj
saline	saline	jj
solution	solution	nn1
.	.	y
For	for	if
10	10	mc
days	day	nnt2
after	after	ii_cs
surgery	surgery	nn1
,	,	y
patients	patient	nn2
completed	complete	vvd_vvn
a	a	at1
questionnaire	questionnaire	nn1
to	to	ii
rate	rate	nn1
their	their	appge
overall	overall	jj_nn1
pain	pain	nn1
and	and	cc
to	to	to
record	record	vvi
their	their	appge
narcotic	narcotic	nn1
consumption	consumption	nn1
and	and	cc
oral	oral	jj_nn1
intake	intake	nn1
.	.	y
At	at	ii
study	study	nn1
's	's	ge
end	end	nn1
,	,	y
there	there	ex
was	be	vbdz
no	no	at_rr%_uh
statistically	statistically	rr
significant	significant	jj
difference	difference	nn1
in	in	ii
pain	pain	nn1
scores	score	nn2
,	,	y
narcotic	narcotic	nn1
use	use	nn1_vv0
,	,	y
and	and	cc
oral	oral	jj_nn1
intake	intake	nn1
between	between	ii
the	the	at
bupivacaine	bupivacaine	nn1
group	group	nn1
and	and	cc
the	the	at
controls	control	nn2
(	(	y
p	xx_p	zz1
=	=	fo
0.13	0.13	mc
,	,	y
0.37	0.37	mc
,	,	y
and	and	cc
0.35	0.35	mc
,	,	y
respectively	respectively	rr
)	)	y
.	.	y
We	we	ppis2
conclude	conclude	vv0
that	that	cst
the	the	at
effects	effect	nn2
of	of	io
perioperative	perioperative	jj
bupivacaine	bupivacaine	nn1
on	on	ii
postoperative	postoperative	jj
pain	pain	nn1
control	control	nn1_vv0
in	in	ii
tonsillectomy	tonsillectomy	nn1
patients	patient	nn2
are	be	vbr
similar	similar	jj
to	to	ii
those	those	dd2
of	of	io
placebo	placebo	nn1
.	.	y
Postoperative	postoperative	jj
pain	pain	nn1
is	be	vbz
the	the	at
primary	primary	jj_nn1
morbidity	morbidity	nn1
associated	associate	vvn
with	with	iw
tonsillectomy	tonsillectomy	nn1
.	.	y
Various	various	jj
surgical	surgical	jj
and	and	cc
pharmacologic	pharmacologic	jj
strategies	strategy	nn2
have	have	vh0
been	be	vbn
undertaken	undertake	vvn
in	in	ii
an	a	at1
effort	effort	nn1
to	to	to
reduce	reduce	vvi
post-tonsillectomy	post-tonsillectomy	jj_nn1
pain	pain	nn1
.	.	y
Surgical	surgical	jj
advancements	advancement	nn2
have	have	vh0
included	include	vvn
the	the	at
introduction	introduction	nn1
of	of	io
harmonic	harmonic	jj
scalpel	scalpel	nn1
tonsillectomy	tonsillectomy	nn1
,	,	y
**27;18489;TOOLONG		nn1_jj
(	(	y
KTP	ktp	np1
)	)	y
laser	laser	nn1
ablation	ablation	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
have	have	vh0
included	include	vvn
the	the	at
perioperative	perioperative	jj
administration	administration	nn1
of	of	io
steroids	steroids	nn2
,	,	y
antibiotics	antibiotic	nn2
,	,	y
and	and	cc
anesthetics	anesthetic	nn2_nn1
.	.	y
The	the	at
influence	influence	nn1
of	of	io
local	local	jj
anesthesia	anesthesia	nn1
on	on	ii
the	the	at
course	course	nn1
of	of	io
post-tonsillectomy	post-tonsillectomy	jj_nn1
pain	pain	nn1
is	be	vbz
ambiguous	ambiguous	jj
.	.	y
Ginstrm	ginstrm	vv0_np1@
et	et	ra21
al	al	ra22
reported	report	vvd
that	that	cst
while	while	cs
intraoperative	intraoperative	jj
infiltration	infiltration	nn1
of	of	io
bupivacaine/epinephrine	bupivacaine/epinephrine	nn1
resulted	result	vvn_vvd
in	in	ii
a	a	at1
significant	significant	jj
decrease	decrease	nn1
in	in	ii
intraoperative	intraoperative	jj
blood	blood	nn1
loss	loss	nn1
,	,	y
it	it	pph1
had	have	vhd
only	only	rr
a	a	at1
marginal	marginal	jj
effect	effect	nn1
on	on	ii
pain	pain	nn1
;	;	y
what	what	ddq
effect	effect	vv0@
it	it	pph1
did	do	vdd
have	have	vhi
was	be	vbdz
principally	principally	rr
seen	see	vvn
in	in	ii
the	the	at
postoperative	postoperative	jj
anesthesia	anesthesia	nn1
care	care	nn1_vv0
unit.	unit	nnu
n1	n1	fo
In	in	ii
a	a	at1
pediatric	pediatric	jj
population	population	nn1
,	,	y
Naja	naja	np1
et	et	ra21
al	al	ra22
found	find	vvd
that	that	cst
a	a	at1
preincision	preincision	nn1
injection	injection	nn1
of	of	io
local	local	jj
anesthesia	anesthesia	nn1
resulted	result	vvn_vvd
in	in	ii
significantly	significantly	rr
less	less	rgr
postoperative	postoperative	jj
pain	pain	nn1
at	at	ii
rest	rest	nn1
,	,	y
on	on	ii
jaw	jaw	nn1
opening	opening	nn1_vvg
,	,	y
and	and	cc
during	during	ii
intake	intake	nn1
of	of	io
a	a	at1
soft	soft	jj
diet	diet	nn1
compared	compare	vvn
with	with	iw
findings	finding	nn2
in	in	ii
a	a	at1
placebo	placebo	nn1
group	group	nn1
and	and	cc
a	a	at1
general	general	jj_nn1
anesthesia	anesthesia	nn1
group.	group	nnu
n2	n2	fo
Previously	previously	rr
published	publish	vvn_vvd_jj@
data	data	nn
by	by	ii
our	our	appge
group	group	nn1
indicated	indicate	vvd_vvn
that	that	cst
patients	patient	nn2
who	who	pnqs
underwent	undergo	vvd
local	local	jj
infiltration	infiltration	nn1
of	of	io
bupivacaine	bupivacaine	nn1
into	into	ii
the	the	at
tonsillar	tonsillar	jj
fossa	fossa	nn1
immediately	immediately	rr_cs@
following	follow	vvg_jj@
tonsillectomy	tonsillectomy	nn1
did	do	vdd
not	not	xx
have	have	vhi
less	less	dar
pain	pain	nn1
than	than	csn
did	do	vdd
placebo	placebo	nn1
controls.	controls	nnu
n3	n3	fo
We	we	ppis2
conducted	conduct	vvd
the	the	at
present	present	nn1
randomized	randomize	vvd
,	,	y
controlled	control	vvd_vvn
,	,	y
double-blind	double-blind	jj_nn1@
,	,	y
prospective	prospective	jj
study	study	nn1
to	to	to
test	test	vvi
our	our	appge
earlier	early	jjr
findings	finding	nn2
and	and	cc
to	to	to
perhaps	perhaps	rr
determine	determine	vvi
if	if	csw@_cs
there	there	ex
is	be	vbz
a	a	at1
role	role	nn1
for	for	if
local	local	jj
anesthesia	anesthesia	nn1
in	in	ii
reducing	reduce	vvg
post-tonsillectomy	post-tonsillectomy	jj_nn1
pain	pain	nn1
.	.	y
Patients	patient	nn2
and	and	cc
methods	method	nn2
Study	study	vv0@_nn1
population	population	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
men	man	nn2
and	and	cc
20	20	mc
women	woman	nn2
(	(	y
mean	mean	jj_vv0
age	age	nn1
:	:	y
24.5	24.5	mc
5.8	5.8	mc
yr	yr	nnu
)	)	y
--		nn1
who	who	pnqs
had	have	vhd
undergone	undergo	vvn
tonsillectomy	tonsillectomy	nn1
for	for	if
either	either	rr
chronic	chronic	jj
tonsillitis	tonsillitis	nn1
or	or	cc
tonsillar	tonsillar	jj
hypertrophy	hypertrophy	nn1
.	.	y
The	the	at
number	number	nn1
of	of	io
infections	infection	nn2
per	per	ii
year	year	nnt1
ranged	range	vvn_vvd
from	from	ii
3	3	mc
to	to	ii
7	7	mc
.	.	y
Surgical	surgical	jj
technique	technique	nn1
.	.	y
All	all	db
patients	patient	nn2
underwent	undergo	vvd
Bovie		np1
cautery-assisted	cautery-assisted	jj_nn1
tonsillectomy	tonsillectomy	nn1
after	after	ii_cs
induction	induction	nn1
of	of	io
general	general	jj_nn1
anesthesia	anesthesia	nn1
.	.	y
Anesthesia	anesthesia	nn1_np1@
was	be	vbdz
standardized	standardize	vvn
for	for	if
all	all	db
patients	patient	nn2
;	;	y
induction	induction	nn1
of	of	io
propofol	propofol	nn1
was	be	vbdz
followed	follow	vvn
by	by	ii
nitrous	nitrous	jj
oxide	oxide	nn1
and	and	cc
isoflurane	isoflurane	nn1
for	for	if
maintenance	maintenance	nn1
.	.	y
Intraoperative	intraoperative	jj
pain	pain	nn1
management	management	nn1
consisted	consist	vvn_vvd
of	of	io
intravenous	intravenous	jj
fentanyl	fentanyl	nn1
2	2	mc
g/kg	g/kg	nnu
,	,	y
and	and	cc
paralysis	paralysis	nn1
was	be	vbdz
managed	manage	vvn
with	with	iw
intravenous	intravenous	jj
mivacurium	mivacurium	nn1
0.1	0.1	mc
mg/kg	mg/kg	nnu
.	.	y
No	no	at
agents	agent	nn2
to	to	to
reverse	reverse	vvi
neuromuscular	neuromuscular	jj
blockade	blockade	nn1
were	be	vbdr
used	use	vvn
.	.	y
Patients	patient	nn2
did	do	vdd
not	not	xx
receive	receive	vvi
perioperative	perioperative	jj
morphine	morphine	nn1
,	,	y
antiemetics	antiemetics	nn2_nn1
,	,	y
or	or	cc
steroids	steroids	nn2
.	.	y
Following	follow	vvg_jj@_ii@
completion	completion	nn1
of	of	io
the	the	at
actual	actual	jj
tonsillectomy	tonsillectomy	nn1
portion	portion	nn1
of	of	io
the	the	at
operation	operation	nn1
,	,	y
patients	patient	nn2
received	receive	vvd_vvn
a	a	at1
10-ml	10-ml	jj
injection	injection	nn1
of	of	io
either	either	dd1_rr
0.5%	0.5%	fo
bupivacaine	bupivacaine	vv0_nn1
with	with	iw
1:200,000	1:200,000	mc
epinephrine	epinephrine	nn1_jj
(	(	y
n	xx_n	zz1
=	=	fo
16	16	mc
)	)	y
or	or	cc
normal	normal	jj
saline	saline	jj
solution	solution	nn1
(	(	y
n	xx_n	zz1
=	=	fo
10	10	mc
)	)	y
.	.	y
Patients	patient	nn2
had	have	vhd
been	be	vbn
randomized	randomize	vvn@
prior	prior	ii21
to	to	ii22
surgery	surgery	nn1
,	,	y
and	and	cc
the	the	at
surgeon	surgeon	nn1
was	be	vbdz
blinded	blind	vvn
to	to	ii
the	the	at
type	type	nn1
of	of	io
injection	injection	nn1
.	.	y
Injections	injection	nn2
were	be	vbdr
made	make	vvn
in	in	ii
a	a	at1
serial	serial	jj_nn1
fashion	fashion	nn1
to	to	to
include	include	vvi
the	the	at
base	base	nn1
of	of	io
the	the	at
uvula	uvula	nn1_jj
and	and	cc
the	the	at
anterior	anterior	jj
and	and	cc
posterior	posterior	jj
tonsillar	tonsillar	jj
fossae	fossa	nn2
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
Then	then	rt
the	the	at
stomach	stomach	nn1
contents	content	nn2
were	be	vbdr
aspirated	aspirate	vvn@_jj@
,	,	y
and	and	cc
patients	patient	nn2
were	be	vbdr
awakened	awaken	vvn
from	from	ii
anesthesia	anesthesia	nn1
and	and	cc
extubated	extubated	vvn
.	.	y
Postoperative	postoperative	jj
care	care	nn1
.	.	y
In	in	ii
the	the	at
postanesthesia	postanesthesia	nn1
care	care	nn1
unit	unit	nn1
,	,	y
patients	patient	nn2
were	be	vbdr
given	give	vvn_jj@
morphine	morphine	nn1
as	as	csa
needed	need	vvn
for	for	if
pain	pain	nn1
and	and	cc
ondansetron	ondansetron	nn1
as	as	csa
needed	need	vvn
for	for	if
nausea	nausea	nn1
and	and	cc
vomiting	vomit	vvg_nn1@
.	.	y
Discharge	discharge	vv0_nn1
medications	medication	nn2
included	include	vvd_vvn
amoxicillin	amoxicillin	nn1
or	or	cc
a	a	at1
first-generation	first-generation	jj
cephalosporin	cephalosporin	nn1
for	for	if
10	10	mc
days	day	nnt2
and	and	cc
either	either	dd1
acetaminophen/codeine	acetaminophen/codeine	nn1
120/12	120/12	mf
mg	mg	nnu
per	per	ii
5	5	mc
ml	ml	nnu
for	for	if
pain	pain	nn1
or	or	cc
another	another	dd1
narcotic	narcotic	nn1
preparation	preparation	nn1
if	if	cs
acetaminophen/codeine	acetaminophen/codeine	nn1
was	be	vbdz
not	not	xx
tolerated	tolerate	vvn
.	.	y
Self-assessments	self-assessment	nn2
.	.	y
For	for	if
10	10	mc
days	day	nnt2
postoperatively	postoperatively	rr
,	,	y
patients	patient	nn2
were	be	vbdr
asked	ask	vvn@
to	to	ii
rate	rate	nn1
their	their	appge
pain	pain	nn1
on	on	ii
a	a	at1
scale	scale	nn1
of	of	io
0	0	mc
(	(	y
none	none	pn
)	)	y
to	to	ii
10	10	mc
(	(	y
severe	severe	jj
)	)	y
.	.	y
They	they	pphs2
were	be	vbdr
also	also	rr
asked	ask	vvn
to	to	to
record	record	vvi
the	the	at
amount	amount	nn1
of	of	io
narcotic	narcotic	nn1
pain	pain	nn1
medication	medication	nn1
they	they	pphs2
required	require	vvd@_vvn
and	and	cc
the	the	at
amount	amount	nn1
of	of	io
oral	oral	jj_nn1
intake	intake	nn1
they	they	pphs2
were	be	vbdr
able	able	jk
to	to	to
achieve	achieve	vvi
.	.	y
Statistical	statistical	jj
analysis	analysis	nn1
.	.	y
The	the	at
data	data	nn
were	be	vbdr
analyzed	analyze	vvn@
according	according	ii21
to	to	ii22
the	the	at
Student	student	nn1
t	t	zz1
test	test	vv0_nn1
,	,	y
and	and	cc
a	a	at1
p	xx_p	nn1@_zz1_nnu@
value	value	nn1
of	of	io
&lt;0.05		fo
was	be	vbdz
considered	consider	vvn
to	to	to
be	be	vbi
statistically	statistically	rr
significant	significant	jj
.	.	y
Approval	approval	nn1
.	.	y
This	this	dd1
study	study	nn1
was	be	vbdz
approved	approve	vvn
by	by	ii
the	the	at
UVA	uva	nn1_np1
Institutional	institutional	jj
Review	review	nn1
Board	board	nn1
.	.	y
Results	result	nn2
Pain	pain	nn1
.	.	y
The	the	at
mean	mean	jj
pain	pain	nn1
scores	score	nn2_vvz@
in	in	ii
the	the	at
treatment	treatment	nn1
group	group	nn1
and	and	cc
the	the	at
control	control	nn1
group	group	nn1
were	be	vbdr
plotted	plot	vvn
over	over	ii
time	time	nnt1
(	(	y
figure	figure	nn1_vv0@
1	1	mc1
)	)	y
.	.	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
groups	group	nn2
(	(	y
p	xx_p	zz1
=	=	fo
0.13	0.13	mc
)	)	y
.	.	y
The	the	at
pain	pain	nn1
in	in	ii
the	the	at
bupivacaine	bupivacaine	nn1
group	group	nn1
did	do	vdd
not	not	xx
begin	begin	vvi
to	to	to
subside	subside	vvi
until	until	cs_ii@
postoperative	postoperative	jj
day	day	nnt1
5	5	mc
.	.	y
Figure	figure	vv0@_nn1
1	1	mc1
.	.	y
Mean	mean	jj_vv0
pain	pain	nn1
scores	score	nn2_vvz@
in	in	ii
the	the	at
2	2	mc
groups	group	nn2
were	be	vbdr
not	not	xx
significantly	significantly	rr
different	different	jj
over	over	ii
time	time	nnt1
(	(	y
p	xx_p	zz1
=	=	fo
0.13	0.13	mc
)	)	y
.	.	y
Narcotic	narcotic	nn1
use	use	nn1
.	.	y
The	the	at
mean	mean	jj
daily	daily	jj
amount	amount	nn1
of	of	io
narcotic	narcotic	nn1
pain	pain	nn1
medication	medication	nn1
used	use	vvn_vvd
in	in	ii
each	each	dd1
group	group	nn1
was	be	vbdz
plotted	plot	vvn
over	over	ii
time	time	nnt1
(	(	y
figure	figure	nn1
2	2	mc
)	)	y
.	.	y
Although	although	cs
the	the	at
bupivacaine	bupivacaine	nn1
group	group	nn1
consumed	consume	vvd_vvn
less	less	dar
narcotic	narcotic	nn1
medication	medication	nn1
on	on	ii
days	day	nnt2
3	3	mc
through	through	ii
6	6	mc
,	,	y
the	the	at
trend	trend	nn1
was	be	vbdz
not	not	xx
statistically	statistically	rr
significant	significant	jj
,	,	y
and	and	cc
there	there	ex
was	be	vbdz
no	no	at
overall	overall	jj_nn1
difference	difference	nn1
between	between	ii
the	the	at
2	2	mc
groups	group	nn2
(	(	y
p	xx_p	zz1
=	=	fo
0.37	0.37	mc
)	)	y
.	.	y
The	the	at
trends	trend	nn2
in	in	ii
both	both	db2
groups	group	nn2
paralleled	parallel	vvd_vvn
the	the	at
respective	respective	jj
declines	decline	vvz
in	in	ii
pain	pain	nn1
scores	score	nn2
.	.	y
Figure	figure	nn1
2	2	mc
.	.	y
No	no	at
significant	significant	jj
difference	difference	nn1
was	be	vbdz
seen	see	vvn
in	in	ii
the	the	at
mean	mean	jj
amount	amount	nn1
of	of	io
narcotic	narcotic	nn1
analgesics	analgesic	nn2
used	use	vvn
by	by	ii
the	the	at
2	2	mc
groups	group	nn2
(	(	y
p	xx_p	zz1
=	=	fo
0.37	0.37	mc
)	)	y
.	.	y
Oral	oral	jj_nn1
intake	intake	nn1
.	.	y
The	the	at
mean	mean	jj
daily	daily	jj_rr
total	total	jj_nn1
oral	oral	jj_nn1
intake	intake	nn1
was	be	vbdz
plotted	plot	vvn
over	over	ii
time	time	nnt1
(	(	y
figure	figure	nn1
3	3	mc
)	)	y
.	.	y
Although	although	cs
there	there	ex
was	be	vbdz
a	a	at1
trend	trend	nn1
toward	toward	ii
greater	great	jjr
intake	intake	nn1
in	in	ii
the	the	at
bupivacaine	bupivacaine	nn1
group	group	nn1
,	,	y
the	the	at
overall	overall	jj_nn1
difference	difference	nn1
did	do	vdd
not	not	xx
reach	reach	vvi
statistical	statistical	jj
significance	significance	nn1
(	(	y
p	xx_p	zz1
=	=	fo
0.35	0.35	mc
)	)	y
.	.	y
Figure	figure	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
groups	group	nn2
in	in	ii
the	the	at
mean	mean	jj
amount	amount	nn1
of	of	io
oral	oral	jj_nn1
intake	intake	nn1
(	(	y
p	xx_p	zz1
=	=	fo
0.35	0.35	mc
)	)	y
.	.	y
Discussion	discussion	nn1
As	as	csa
mentioned	mention	vvn
,	,	y
several	several	da2
surgical	surgical	jj
and	and	cc
medical	medical	jj
strategies	strategy	nn2
have	have	vh0
been	be	vbn
undertaken	undertake	vvn
in	in	ii
an	a	at1
effort	effort	nn1
to	to	to
reduce	reduce	vvi
post-tonsillectomy	post-tonsillectomy	jj_nn1
pain	pain	nn1
:	:	y
Surgical	surgical	jj
technique	technique	nn1
.	.	y
A	a	at1_zz1
series	series	nn
of	of	io
recently	recently	rr
published	publish	vvn_vvd_jj@
reports	report	nn2
have	have	vh0
suggested	suggest	vvn
that	that	cst_dd1
surgical	surgical	jj
technique	technique	nn1
may	may	vm
have	have	vhi
an	a	at1
impact	impact	nn1
on	on	ii
post-tonsillectomy	post-tonsillectomy	jj_nn1
pain	pain	nn1
outcomes	outcome	nn2
.	.	y
Lister	lister	np1
et	et	ra21
al	al	ra22
found	find	vvd
that	that	cst_dd1
pediatric	pediatric	jj
patients	patient	nn2
who	who	pnqs
underwent	undergo	vvd
microdebrider	microdebrider	nn1_vv0
intracapsular	intracapsular	jj
tonsillotomy	tonsillotomy	nn1
on	on	ii
one	one	mc1
tonsil	tonsil	nn1
and	and	cc
electrocautery	electrocautery	jj
extracapsular	extracapsular	jj
tonsillectomy	tonsillectomy	nn1
on	on	ii
the	the	at
other	others	nn1@_jj
reported	report	vvd_vvn
significantly	significantly	rr
less	less	dar
pain	pain	nn1
on	on	ii
the	the	at
microdebrider	microdebrider	nn1
side	side	nn1
on	on	ii
postoperative	postoperative	jj
days	day	nnt2
1	1	mc1
through	through	ii
9.	9	mc
n4	n4	fo
However	however	rr
,	,	y
Sobol	sobol	np1
et	et	ra21
al	al	ra22
observed	observe	vvd
no	no	at
difference	difference	nn1
in	in	ii
postoperative	postoperative	jj
pain	pain	nn1
between	between	ii
children	child	nn2
who	who	pnqs
underwent	undergo	vvd
microdebrider	microdebrider	nn1_vv0
intracapsular	intracapsular	jj
tonsillotomy	tonsillotomy	nn1
or	or	cc
monopolar	monopolar	jj
electrocautery	electrocautery	jj_nn1
tonsillectomy	tonsillectomy	nn1
;	;	y
also	also	rr
,	,	y
there	there	ex
was	be	vbdz
no	no	at
significant	significant	jj
difference	difference	nn1
in	in	ii
the	the	at
total	total	jj_nn1
number	number	nn1
of	of	io
days	day	nnt2
before	before	ii_cs
patients	patient	nn2
returned	return	vvn_vvd
to	to	ii
normal	normal	jj
activity	activity	nn1
,	,	y
although	although	cs
there	there	ex
was	be	vbdz
a	a	at1
significant	significant	jj
difference	difference	nn1
in	in	ii31
favor	favor	ii32
of	of	ii33
microdebrider	microdebrider	nn1
tonsillectomy	tonsillectomy	nn1
in	in	ii
the	the	at
return	return	nn1
to	to	ii
a	a	at1
normal	normal	jj
diet.	diet	nnu
n5	n5	fo
Polites	polites	nn2
et	et	ra21
al	al	ra22
found	find	vvd
that	that	cst
adults	adult	nn2
who	who	pnqs
underwent	undergo	vvd
Coblation-assisted	coblation-assisted	jj
tonsillectomy	tonsillectomy	nn1
reported	report	vvd_vvn
significantly	significantly	rr
less	less	dar
pain	pain	nn1
on	on	ii
postoperative	postoperative	jj
days	day	nnt2
1	1	mc1
and	and	cc
3	3	mc
than	than	csn
did	do	vdd
those	those	dd2
who	who	pnqs
underwent	undergo	vvd
dissection	dissection	nn1
tonsillectomy	tonsillectomy	nn1
;	;	y
there	there	ex
was	be	vbdz
no	no	at
significant	significant	jj
difference	difference	nn1
in	in	ii
total	total	jj_nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
lower	low	jjr
incidence	incidence	nn1
of	of	io
neck	neck	nn1
pain	pain	nn1
(	(	y
and	and	cc
dehydration	dehydration	nn1
)	)	y
in	in	ii
children	child	nn2
who	who	pnqs
underwent	undergo	vvd
Coblation	coblation	nn1
techniques	technique	nn2
as	as	ii31
opposed	opposed	ii32
to	to	ii33
electrocautery.	electrocautery	nnu
n7	n7	fo
Overall	overall	rr_nn1
,	,	y
the	the	at
data	data	nn
seem	seem	vv0
to	to	to
suggest	suggest	vvi
that	that	dd1_cst
surgical	surgical	jj
technique	technique	nn1
may	may	vm
offer	offer	vvi
some	some	dd
benefit	benefit	nn1_vv0
in	in	ii
the	the	at
early	early	jj
reduction	reduction	nn1
of	of	io
pain	pain	nn1
following	follow	vvg_ii@_nn1@
tonsillectomy	tonsillectomy	nn1
.	.	y
Steroid	steroid	jj_nn1
injections	injection	nn2
.	.	y
Ohlms		np1@_nn2
et	et	ra21
al	al	ra22
conducted	conduct	vvd
a	a	at1
randomized	randomized	jj@
,	,	y
double-blind	double-blind	jj_nn1@
,	,	y
placebo-controlled	placebo-controlled	jj
clinical	clinical	jj
trial	trial	nn1
of	of	io
a	a	at1
single	single	jj
intravenous	intravenous	jj
dose	dose	nn1
of	of	io
dexamethasone	dexamethasone	nn1
in	in	ii
children	child	nn2
and	and	cc
found	find	vvd
no	no	at
significant	significant	jj
differences	difference	nn2
in	in	ii
postoperative	postoperative	jj
pain	pain	nn1
between	between	ii
the	the	at
treated	treated	jj@
patients	patient	nn2
and	and	cc
the	the	at
controls.	controls	nnu
n8	n8	fo
Nor	nor	cc
did	do	vdd
they	they	pphs2
find	find	vvi
any	any	dd
differences	difference	nn2
in	in	ii
nausea	nausea	nn1
,	,	y
emesis	emesis	nn1
,	,	y
halitosis	halitosis	nn1
,	,	y
the	the	at
need	need	nn1
for	for	if
analgesic	analgesic	nn1_jj@
medications	medication	nn2
,	,	y
the	the	at
type	type	nn1
of	of	io
diet	diet	nn1
,	,	y
and	and	cc
activity	activity	nn1
levels	level	nn2
.	.	y
Conversely	conversely	rr
,	,	y
Afman	afman	np1
et	et	ra21
al	al	ra22
recently	recently	rr
reported	report	vvn_vvd
a	a	at1
meta-analysis	meta-analysis	nn1
of	of	io
eight	eight	mc
randomized	randomize	vvd_jj@
,	,	y
controlled	control	vvd_vvn
,	,	y
double-blind	double-blind	jj
studies	study	nn2
of	of	io
a	a	at1
single	single	jj
intraoperative	intraoperative	jj
dose	dose	nn1
of	of	io
corticosteroid	corticosteroid	nn1_jj
in	in	ii
children	child	nn2
and	and	cc
found	find	vvd_vvn
that	that	cst
there	there	ex
was	be	vbdz
a	a	at1
significant	significant	jj
reduction	reduction	nn1
in	in	ii
pain	pain	nn1
2	2	mc
to	to	ii
7	7	mc
hours	hour	nnt2
postoperatively	postoperatively	rr
in	in	ii
those	those	dd2
patients	patient	nn2
who	who	pnqs
had	have	vhd
been	be	vbn
administered	administer	vvn
between	between	ii
0.4	0.4	mc
and	and	cc
1.0	1.0	mc
mg/kg	mg/kg	nnu
of	of	io
dexamethasone.	dexamethasone	nnu
n9	n9	fo
Antibiotic	antibiotic	nn1
injections	injection	nn2
.	.	y
Data	data	nn
from	from	ii
a	a	at1
seven-study	seven-study	jj_nn1
meta-analysis	meta-analysis	nn1
conducted	conduct	vvn
by	by	ii
Burkart	burkart	np1_nn1
and	and	cc
Steward	steward	nn1
demonstrated	demonstrate	vvd_vvn
that	that	cst
both	both	db2_rr
adult	adult	nn1_jj@
and	and	cc
pediatric	pediatric	jj
patients	patient	nn2
who	who	pnqs
had	have	vhd
been	be	vbn
treated	treat	vvn
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
amoxicillin/clavulanate	amoxicillin/clavulanate	nn1
--		nn1
experienced	experience	vvd_vvn
a	a	at1
significantly	significantly	rr
earlier	early	jjr_rrr
return	return	nn1_vv0
to	to	ii
a	a	at1
normal	normal	jj
diet	diet	nn1
and	and	cc
normal	normal	jj
activity	activity	nn1
,	,	y
but	but	ccb
they	they	pphs2
found	find	vvd
no	no	at
significant	significant	jj
difference	difference	nn1
in	in	ii
postoperative	postoperative	jj
pain	pain	nn1
scores.	scores	nnu
n10	n10	fo
A	a	zz1
similar	similar	jj
lack	lack	nn1
of	of	io
efficacy	efficacy	nn1
with	with	ii31
regard	regard	ii32
to	to	ii33
pain	pain	nn1
was	be	vbdz
found	find	vvn
in	in	ii
a	a	at1
meta-analysis	meta-analysis	nn1
of	of	io
five	five	mc
trials	trial	nn2
of	of	io
intra-	intra-	nn1_jj
and/or	and/or	cc
postoperative	postoperative	jj
antibiotics	antibiotic	nn2
reported	report	vvn
by	by	ii
Dhiwakar		np1
et	et	ra21
al.	al	ra22
n11	n11	fo
On	on	ii
the	the	at
other	other	jj
hand	hand	nn1
,	,	y
a	a	at1
single-day	single-day	jj_nnt1
regimen	regimen	nn1
of	of	io
a	a	at1
topical	topical	jj
antibiotic	antibiotic	nn1
was	be	vbdz
shown	show	vvn
by	by	ii
Mann	mann	np1
et	et	ra21
al	al	ra22
to	to	to
be	be	vbi
more	more	rgr
effective	effective	jj
than	than	csn
placebo	placebo	nn1
in	in	ii
reducing	reduce	vvg
postoperative	postoperative	jj
pain	pain	nn1
in	in	ii
adults.	adult	nnu
n12	n12	fo
Anesthetic	anesthetic	jj_nn1
injections	injection	nn2
.	.	y
As	as	csa
mentioned	mention	vvn
,	,	y
the	the	at
influence	influence	nn1
of	of	io
local	local	jj
anesthetic	anesthetic	jj
injections	injection	nn2
on	on	ii
reducing	reduce	vvg
post-tonsillectomy	post-tonsillectomy	jj_nn1
pain	pain	nn1
is	be	vbz
equivocal	equivocal	jj
.	.	y
The	the	at
timing	timing	nn1
of	of	io
injections	injection	nn2
(	(	y
i.e.	ie	rex
,	,	y
preincision	preincision	nn1
or	or	cc
postoperative	postoperative	jj
)	)	y
does	do	vdz
not	not	xx
appear	appear	vvi
to	to	to
have	have	vhi
any	any	dd
effect	effect	nn1
on	on	ii
self-rated	self-rated	jj_nn1
pain	pain	nn1
scores	score	nn2
.	.	y
In	in	ii
our	our	appge
study	study	nn1
,	,	y
the	the	at
lack	lack	nn1
of	of	io
bupivacaine	bupivacaine	nn1
effect	effect	nn1
seen	see	vvn
subjectively	subjectively	rr
was	be	vbdz
confirmed	confirm	vvn
by	by	ii
objective	objective	jj_nn1
data	data	nn
--		nn1_jj
that	that	rex21
is	is	rex22
,	,	y
the	the	at
amounts	amount	nn2
of	of	io
narcotic	narcotic	nn1
consumption	consumption	nn1
and	and	cc
daily	daily	rr_jj
oral	oral	jj_nn1
intake	intake	nn1
.	.	y
The	the	at
findings	finding	nn2
of	of	io
the	the	at
present	present	jj_nn1
study	study	nn1
also	also	rr
confirm	confirm	vv0
those	those	dd2
of	of	io
our	our	appge
earlier	early	jjr
study.	study	nnu
n3	n3	fo
However	however	rr
,	,	y
the	the	at
difficulties	difficulty	nn2
of	of	io
assessing	assess	vvg
subjective	subjective	jj
data	data	nn
such	such	ii21
as	as	ii22
pain	pain	nn1
scores	score	nn2
are	be	vbr
well	well	rr
known	know	vvn
,	,	y
and	and	cc
the	the	at
use	use	nn1
of	of	io
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
tool.	tool	nnu
n13	n13	fo
The	the	at
half-life	half-life	nn1
of	of	io
bupivacaine	bupivacaine	nn1
is	be	vbz
2.7	2.7	mc
hours	hour	nnt2
in	in	ii
adults	adult	nn2
.	.	y
Systemic	systemic	jj
absorption	absorption	nn1
of	of	io
bupivacaine	bupivacaine	nn1
is	be	vbz
dependent	dependent	jj
on	on	ii
the	the	at
total	total	jj_nn1
dose	dose	nn1
and	and	cc
concentration	concentration	nn1
administered	administer	vvn_vvd@
,	,	y
the	the	at
route	route	nn1
of	of	io
administration	administration	nn1
,	,	y
vascularity	vascularity	nn1
at	at	ii
the	the	at
administration	administration	nn1
site	site	nn1
,	,	y
and	and	cc
the	the	at
use	use	nn1
of	of	io
epinephrine	epinephrine	nn1_jj
.	.	y
Epinephrine	epinephrine	np1@_nn1_jj
used	use	vvd
at	at	ii
a	a	at1
concentration	concentration	nn1
of	of	io
1:200,000	1:200,000	mc
usually	usually	rr
reduces	reduce	vvz
the	the	at
rate	rate	nn1
of	of	io
absorption	absorption	nn1
and	and	cc
the	the	at
peak	peak	nn1
plasma	plasma	nn1
concentration	concentration	nn1
of	of	io
bupivacaine	bupivacaine	nn1
,	,	y
thus	thus	rr
allowing	allow	vvg
for	for	if
larger	large	jjr
total	total	jj_nn1
doses	dose	nn2
,	,	y
which	which	ddq
may	may	vm
prolong	prolong	vvi
its	its	z'
duration	duration	nn1
of	of	io
action	action	nn1
.	.	y
With	with	ii31
respect	respect	ii32
to	to	ii33
the	the	at
pharmacokinetic	pharmacokinetic	jj
properties	property	nn2
of	of	io
bupivacaine	bupivacaine	nn1
,	,	y
both	both	db2_rr
the	the	at
time	time	nnt1
it	it	pph1
takes	take	vvz
to	to	to
achieve	achieve	vvi
its	its	z'
maximum	maximum	jj_nn1
analgesic	analgesic	nn1_jj@
effect	effect	nn1
and	and	cc
the	the	at
specific	specific	jj
route	route	nn1
of	of	io
administration	administration	nn1
warrant	warrant	vv0_nn1
further	far	jjr@_rrr
study	study	nn1
.	.	y
In	in	ii
the	the	at
present	present	jj_nn1
study	study	nn1
,	,	y
we	we	ppis2
did	do	vdd
not	not	xx
examine	examine	vvi
the	the	at
effect	effect	nn1
of	of	io
bupivacaine	bupivacaine	nn1
during	during	ii
the	the	at
immediate	immediate	jj
postoperative	postoperative	jj
period	period	nn1
(	(	y
i.e.	ie	rex
,	,	y
within	within	ii
hours	hour	nnt2
of	of	io
administration	administration	nn1
)	)	y
,	,	y
and	and	cc
thus	thus	rr
we	we	ppis2
do	do	vd0
not	not	xx
know	know	vvi
if	if	csw@_cs
its	its	z'
use	use	nn1
had	have	vhd
an	a	at1
)	)	y
,	,	y
significant	significant	jj
impact	impact	nn1
on	on	ii
the	the	at
amount	amount	nn1
of	of	io
time	time	nnt1
patients	patient	nn2
spent	spend	vvn_vvd
in	in	ii
the	the	at
recovery	recovery	nn1
suite	suite	nn1
.	.	y
Moreover	moreover	rr
,	,	y
subcutaneous	subcutaneous	jj
delivery	delivery	nn1
of	of	io
microencapsulated	microencapsulated	jj@
bupivacaine	bupivacaine	nn1
has	have	vhz
been	be	vbn
shown	show	vvn
to	to	to
extend	extend	vvi
its	its	z'
analgesic	analgesic	nn1_jj@
effect	effect	nn1
for	for	if
as	as	cs31_rg
long	long	cs32_rr
as	as	cs33_csa
96	96	mc
hours	hour	nnt2
without	without	iw
delaying	delay	vvg
its	its	z'
onset	onset	nn1
of	of	io
action.	action	nnu
n14	n14	fo
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
significantly	significantly	rr
reduce	reduce	vvi
postoperative	postoperative	jj
pain	pain	nn1
,	,	y
the	the	at
hypothesis	hypothesis	nn1
that	that	cst_dd1
local	local	jj
anesthetics	anesthetic	nn2_nn1
in	in	rr21
general	general	rr22
may	may	vm
do	do	vdi
so	so	rr
should	should	vm
not	not	xx
be	be	vbi
abandoned	abandon	vvn
as	as	csa_ii@_rg@
newer	new	jjr
preparations	preparation	nn2
with	with	iw
more	more	rgr_dar
sustained	sustained	jj
analgesic	analgesic	nn1_jj@
effects	effect	nn2
become	become	vv0
available	available	jj
.	.	y
References	reference	nn2
(	(	y
n1	n1	fo
.	.	y
)	)	y
Ginstrm	ginstrm	vv0
R	xx_r	zz1
,	,	y
Silvola	silvola	np1
J	xx_j	zz1_np1@
,	,	y
Saarnivaara		np1
L.	l	zz
Local	local	nn1_jj@
bupivacaine-epinephrine	bupivacaine-epinephrine	nn1_jj
infiltration	infiltration	nn1
combined	combine	vvn
with	with	iw
general	general	jj
anesthesia	anesthesia	nn1
for	for	if
adult	adult	nn1_jj@
tonsillectomy	tonsillectomy	nn1
.	.	y
Acta	acta	np1@_nn1
Otolaryngol		np1_nn1
2005	2005	mc
;	;	y
125(9):972-5.		fo
(	(	y
n2	n2	fo
.	.	y
)	)	y
Naja	naja	np1@
MZ	mz	np1
,	,	y
El-Rajab		np1
M	m	zz1_nn1
,	,	y
Kabalan	kabalan	np1_jj
W	w	zz1_np1@
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Pre-incisional	pre-incisional	jj
infiltration	infiltration	nn1
for	for	if
pediatric	pediatric	jj
tonsillectomy	tonsillectomy	nn1
:	:	y
A	a	zz1_at1@
randomized	randomized	jj@_vvd
double-blind	double-blind	jj
clinical	clinical	jj
trial	trial	nn1
.	.	y
Int	int	zz_j
J	xx_j	zz1_np1@
Pediatr	pediatr	np1
Otorhinolaryngol		np1_nn1
2005	2005	mc
;	;	y
69(10):1333-41.		fo
(	(	y
n3	n3	fo
.	.	y
)	)	y
Kountakis		np1@_nn1
SE	se	np1_nd1
.	.	y
Effectiveness	effectiveness	nn1
of	of	io
perioperative	perioperative	jj
bupivacaine	bupivacaine	nn1
infiltration	infiltration	nn1
in	in	ii
tonsillectomy	tonsillectomy	nn1
patients	patient	nn2
.	.	y
Am	be	vbm
J	xx_j	np1@
Otolaryngol		np1_nn1
2002	2002	mc
;	;	y
23(2):76-80.		fo
(	(	y
n4	n4	fo
.	.	y
)	)	y
Lister	lister	np1
MT	mt	nnl1
,	,	y
Cunningham	cunningham	np1
MJ	mj	np1
,	,	y
Benjamin	benjamin	np1
B	b	zz1_np1@
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Microdebrider	microdebrider	vv0_nn1
tonsillotomy	tonsillotomy	nn1
vs.	vs	ii
electrosurgical	electrosurgical	jj
tonsillectomy	tonsillectomy	nn1
:	:	y
A	a	zz1_at1@
randomized	randomize	vvd_jj@
,	,	y
double-blind	double-blind	jj_nn1@
,	,	y
paired	pair	vvd_vvn
control	control	nn1
study	study	nn1
of	of	io
postoperative	postoperative	jj
pain	pain	nn1
.	.	y
Arch	arch	jj_nn1
Otolaryngol	otolaryngol	nn1
Head	head	nn1
Neck	neck	nn1
Surg	surg	nn1_np1_vv0
2006	2006	mc
;	;	y
132(6):599-604.		fo
(	(	y
n5	n5	fo
.	.	y
)	)	y
Sobol	sobol	vv0_np1@
SE	se	nd1_np1
,	,	y
Wetmore	wetmore	np1
RF	rf	np1
,	,	y
Marsh	marsh	np1
RR	xx_rr	np1
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Postoperative	postoperative	jj
recovery	recovery	nn1
after	after	ii_cs
microdebrider	microdebrider	nn1_vv0
intracapsular	intracapsular	jj
or	or	cc
monopolar	monopolar	jj
electrocautery	electrocautery	jj_nn1
tonsillectomy	tonsillectomy	nn1
:	:	y
A	a	zz1_at1@
prospective	prospective	jj
,	,	y
randomized	randomize	vvd
,	,	y
single-blinded	single-blinded	jj_nn1
study	study	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
n6	n6	fo
.	.	y
)	)	y
Polites		np1@_nn2
N	xx_n	zz1_np1@
,	,	y
Joniau		np1
S	s	zz1_np1@
,	,	y
Wabnitz		np1
D	d	zz1_np1@
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Postoperative	postoperative	jj
pain	pain	nn1
following	follow	vvg_ii@_nn1@
coblation	coblation	nn1
tonsillectomy	tonsillectomy	nn1
:	:	y
Randomized	randomized	jj
clinical	clinical	jj
trial	trial	nn1
.	.	y
ANZ	anz	np1_vv0
J	xx_j	np1@_zz1
Surg	surg	np1_vv0_nn1
2006	2006	mc
;	;	y
76(4):226-9.		fo
(	(	y
n7	n7	fo
.	.	y
)	)	y
Glade	glade	vv0_nn1
RS	rs	nn1
,	,	y
Pearson	pearson	np1
SE	se	np1_nd1
,	,	y
Zalzal		np1
GH	gh	np1
,	,	y
Choi	choi	np1
SS	ss	np1
.	.	y
Coblation	coblation	nn1_np1@
adenotonsillectomy	adenotonsillectomy	nn1
:	:	y
An	a	at1
improvement	improvement	nn1
over	over	ii
electrocautery	electrocautery	jj_nn1
technique	technique	nn1
?	?	y
Otolaryngol	otolaryngol	vv0_nn1
Head	head	nn1
Neck	neck	nn1
Surg	surg	nn1_np1_vv0
2006	2006	mc
;	;	y
134(5):852-5.		fo
(	(	y
n8	n8	fo
.	.	y
)	)	y
Ohlms		np1@
LA	la	np1
,	,	y
Wilder	wild	jjr
RT	rt	nn1
,	,	y
Weston	weston	np1
B.	b	np1
Use	use	nn1
of	of	io
intraoperative	intraoperative	jj
corticosteroids	corticosteroid	nn2
in	in	ii
pediatric	pediatric	jj
tonsillectomy	tonsillectomy	nn1
.	.	y
Arch	arch	jj_nn1
Otolaryngol	otolaryngol	nn1
Head	head	nn1
Neck	neck	nn1
Surg	surg	nn1_np1_vv0
1995	1995	mc
;	;	y
121(7):737-42.		fo
(	(	y
n9	n9	fo
.	.	y
)	)	y
Afman	afman	np1@_nn1
CE	ce	np1_nn1
,	,	y
Welge	welge	np1
JA	ja	np1_fw
,	,	y
Steward	steward	nn1_vv0@
DL	dl	mc
.	.	y
Steroids	steroids	nn2
for	for	if
post-tonsillectomy	post-tonsillectomy	jj_nn1
pain	pain	nn1
reduction	reduction	nn1
:	:	y
Meta-analysis	meta-analysis	nn1
of	of	io
randomized	randomized	jj@
controlled	controlled	jj@
trials	trial	nn2
.	.	y
Otolaryngol	otolaryngol	vv0_nn1
Head	head	nn1
Neck	neck	nn1
Surg	surg	nn1_np1_vv0
2006	2006	mc
;	;	y
134(2)		fo
:	:	y
181-6.		mcmc
(	(	y
n10	n10	fo
.	.	y
)	)	y
Burkart	burkart	vv0
CM	cm	nnu
,	,	y
Steward	steward	nn1_vv0@
DL	dl	mc
.	.	y
Antibiotics	antibiotic	nn2
for	for	if
reduction	reduction	nn1
of	of	io
posttonsillectomy	posttonsillectomy	nn1
morbidity	morbidity	nn1
:	:	y
A	a	at1@_zz1
meta-analysis	meta-analysis	nn1
.	.	y
Laryngoscope	laryngoscope	nn1_np1@
2005	2005	mc
;	;	y
115(6)		fo
:	:	y
997-1002.		mcmc
(	(	y
n11	n11	fo
.	.	y
)	)	y
Dhiwakar	dhiwakar	vv0_nn1
M	m	zz1_nn1
,	,	y
Eng	eng	np1
CY	cy	np1
,	,	y
Selvaraj		np1
S	s	zz1_np1@
,	,	y
McIerrow		np1
WS	w	np2
.	.	y
Antibiotics	antibiotic	nn2
to	to	to
improve	improve	vvi
recovery	recovery	nn1
following	follow	vvg_ii@_nn1@
tonsillectomy	tonsillectomy	nn1
:	:	y
A	a	zz1_at1@
systematic	systematic	jj
review	review	nn1
.	.	y
Otolaryngol	otolaryngol	vv0_nn1
Head	head	nn1
Neck	neck	nn1
Surg	surg	nn1_np1_vv0
2006	2006	mc
;	;	y
134(3):357-64.		fo
(	(	y
n12	n12	fo
.	.	y
)	)	y
Mann	mann	np1
EA	ea	np1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
of	of	io
topical	topical	jj
antibiotic	antibiotic	nn1
therapy	therapy	nn1
on	on	ii
recovery	recovery	nn1
after	after	ii_cs
tonsillectomy	tonsillectomy	nn1
in	in	ii
adults	adult	nn2
.	.	y
Otolaryngol	otolaryngol	vv0_nn1
Head	head	nn1
Neck	neck	nn1
Surg	surg	nn1_np1_vv0
1999	1999	mc
;	;	y
121(3):277-82.		fo
(	(	y
n13	n13	fo
.	.	y
)	)	y
Collins	collins	np1
SL	sl	np1
,	,	y
Moore	moore	np1
RA	ra	nna
,	,	y
McQuay	mcquay	np1
HJ	hj	np1
.	.	y
The	the	at
visual	visual	jj
analogue	analogue	jj_nn1
pain	pain	nn1
intensity	intensity	nn1
scale	scale	nn1
:	:	y
What	what	ddq
is	be	vbz
moderate	moderate	jj
pain	pain	nn1
in	in	ii
millimetres	millimetre	nnu2
?	?	y
Pain	pain	nn1
1997	1997	mc
;	;	y
72(1-2):95-7.		fo
(	(	y
n14	n14	fo
.	.	y
)	)	y
Kopacz	kopacz	vv0_nn1
DJ	dj	nn1
,	,	y
Bernards	bernards	np2
CM	cm	nnu
,	,	y
Allen	allen	np1
HW	hw	np1
,	,	y
et	et	ra21
al	al	ra22
.	.	y
A	a	at1
model	model	nn1
to	to	to
evaluate	evaluate	vvi
the	the	at
pharmacokinetic	pharmacokinetic	jj_nn1@
and	and	cc
pharmacodynamic	pharmacodynamic	jj
variables	variable	nn2
of	of	io
extended-release	extended-release	jj_nn1
products	product	nn2
using	use	vvg
in	in	jj21
vivo	vivo	jj22
tissue	tissue	nn1
microdialysis	microdialysis	nn1
in	in	ii
humans	human	nn2
:	:	y
Bupivacaine-loaded	bupivacaine-loaded	jj_nn1
microcapsules	microcapsules	nn2
.	.	y
Anesth		np1@_nn1
Analg		np1_nn1
2003	2003	mc
;	;	y
97(1):124-31		fo
.	.	y
By	by	ii
Tammara	tammara	np1
L.	l	zz
Watts	watts	np1
,	,	y
MD	md	nna
,	,	y
PhD	phd	nn1
and	and	cc
Stilianos	stilianos	np1
E.	e	np1
Kountakis		np1
,	,	y
MD	md	nna
,	,	y
PhD	phd	nn1
From	from	ii
the	the	at
Department	department	nn1
of	of	io
Otolaryngology-Head	otolaryngology-head	nn1
and	and	cc
Neck	neck	nn1_vv0@
Surgery	surgery	nn1
,	,	y
Medical	medical	jj
College	college	nn1
of	of	io
Georgia	georgia	np1
,	,	y
Augusta	augusta	np1
.	.	y
Corresponding	corresponding	jj_vvg
author	author	nn1
:	:	y
Stilianos	stilianos	np1
E.	e	np1
Kountakis		np1
,	,	y
MD	md	nna
,	,	y
Department	department	nn1
of	of	io
Otolaryngology-Head	otolaryngology-head	nn1
and	and	cc
Neck	neck	nn1_vv0@
Surgery	surgery	nn1
,	,	y
Medical	medical	jj
College	college	nn1
of	of	io
Georgia	georgia	np1
,	,	y
1120	1120	mc
15th	15th	md
St.	st	np1
,		np1
Augusta	augusta	np1
,	,	y
GA	ga	np1
30912	30912	mc
.	.	y
E-mail	e-mail	nn1_vv0@
:	:	y
skountakis@mcg.edu		fo
